martes, 26 de mayo de 2020

FDA’s Woodcock to stop drug approval work to focus on Covid-19 vaccines

FDA’s Woodcock to stop drug approval work to focus on Covid-19 vaccines

D.C. Diagnosis

Nicholas Florko

More of STAT's coronavirus coverage 

FDA’s top regulator, Janet Woodcock, is being reassigned to focus solely on helping develop a coronavirus vaccine. 

Ian Haydon experienced a severe adverse reaction to Moderna's Covid-19 vaccine candidate. He’s still a believer
In the public imagination, vaccines are often seen effectively as cure-alls, like inoculations against measles. But what if vaccines against Covid-19 are more like flu shots?
What a big new study on using malaria drugs like hydroxychloroquine as Covid-19 treatments tells us — and what it doesn’t. 
Some 80 million babies worldwide are at higher risk of diseases like diphtheria, measles, and polio as the Covid-19 pandemic hinders routine vaccinations. 
The digital tools being deployed to combat Covid-19 have thrust health data privacy into the spotlight, drawing fresh scrutiny from federal lawmakers. 

No hay comentarios: